Stanley-Laman Group’s Johnson & Johnson JNJ Stock Holding History

Stanley-Laman Group’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-825	Closed	-$202K	–	311
2026 Q1	$202K	Buy	+825	New	+$192K	0.02%	276
2025 Q3	–	Sell	-2,047	Closed	-$313K	–	285
2025 Q2	$313K	Buy	2,047 +285	+16%	+$43.8K	0.05%	229
2025 Q1	$292K	Sell	1,762 -645	-27%	-$101K	0.05%	236
2024 Q4	$348K	Buy	2,407 +674	+39%	+$104K	0.05%	233
2024 Q3	$281K	Hold	1,733	–	–	0.04%	243
2024 Q2	$253K	Hold	1,733	–	–	0.04%	248
2024 Q1	$274K	Hold	1,733	–	–	0.04%	223
2023 Q4	$272K	Sell	1,733 -173	-9%	-$26.5K	0.04%	212
2023 Q3	$297K	Sell	1,906 -4	-0.2%	-$660	0.05%	203
2023 Q2	$316K	Buy	1,910 +43	+2%	+$6.94K	0.05%	195
2023 Q1	$289K	Buy	+1,867	New	+$301K	0.05%	197
2022 Q3	–	Sell	-1,244	Closed	-$221K	–	261
2022 Q2	$221K	Buy	+1,244	New	+$222K	0.04%	250
2021 Q3	–	Sell	-16,644	Closed	-$2.74M	–	264
2021 Q2	$2.74M	Buy	16,644 +1,546	+10%	+$256K	0.39%	64
2021 Q1	$2.48M	Buy	15,098 +681	+5%	+$110K	0.41%	59
2020 Q4	$2.27M	Buy	14,417 +1,224	+9%	+$181K	0.4%	60
2020 Q3	$1.96M	Buy	13,193 +92	+0.7%	+$13.6K	0.43%	57
2020 Q2	$1.84M	Buy	13,101 +5,907	+82%	+$861K	0.44%	59
2020 Q1	$943K	Buy	7,194 +614	+9%	+$87.1K	0.29%	100
2019 Q4	$960K	Sell	6,580 -686	-9%	-$93K	0.23%	153
2019 Q3	$940K	Sell	7,266 -1,045	-13%	-$138K	0.23%	140
2019 Q2	$1.16M	Buy	8,311 +221	+3%	+$30.6K	0.28%	114
2019 Q1	$1.13M	Buy	8,090 +205	+3%	+$27.5K	0.27%	110
2018 Q4	$1.02M	Buy	7,885 +3	+0%	+$418	0.28%	106
2018 Q3	$1.09M	Sell	7,882 -230	-3%	-$30.6K	0.27%	117
2018 Q2	$984K	Buy	8,112 +503	+7%	+$62.8K	0.22%	130
2018 Q1	$975K	Sell	7,609 -191	-2%	-$25.8K	0.22%	127
2017 Q4	$1.09M	Sell	7,800 -203	-3%	-$28.3K	0.24%	116
2017 Q3	$1.04M	Buy	8,003 +214	+3%	+$28.4K	0.28%	95
2017 Q2	$1.03M	Buy	7,789 +102	+1%	+$13K	0.28%	85
2017 Q1	$957K	Sell	7,687 -5,724	-43%	-$684K	0.26%	101
2016 Q4	$1.54M	Buy	13,411 +2,961	+28%	+$342K	0.48%	69
2016 Q3	$1.23M	Sell	10,450 -812	-7%	-$98.5K	0.51%	52
2016 Q2	$1.37M	Sell	11,262 -8,642	-43%	-$982K	0.53%	46
2016 Q1	$2.15M	Sell	19,904 -1,784	-8%	-$185K	0.4%	53
2015 Q4	$2.23M	Buy	21,688 +219	+1%	+$22K	0.38%	86
2015 Q3	$2M	Buy	21,469 +936	+5%	+$90.5K	0.41%	73
2015 Q2	$2M	Hold	20,533	–	–	0.37%	85
2015 Q1	$2.07M	Sell	20,533 -2,463	-11%	-$250K	0.38%	82
2014 Q4	$2.4M	Buy	22,996 +2,863	+14%	+$302K	0.46%	70
2014 Q3	$2.15M	Buy	20,133 +800	+4%	+$83K	0.42%	81
2014 Q2	$2.02M	Buy	19,333 +1,000	+5%	+$101K	0.37%	88
2014 Q1	$1.8M	Buy	+18,333	New	+$1.7M	0.31%	104

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Stanley-Laman Group's JNJ Position: Q2 2026 in Review

Stanley-Laman Group sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 825 shares — an estimated $202K sold.

Stanley-Laman Group first reported a position in JNJ in Q1 2014 and held it in 42 quarters. The position peaked at $2.74M in Q2 2021. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Stanley-Laman Group reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
Stanley-Laman Group sold 825 Johnson & Johnson shares in Q2 2026, an estimated $202K.
Stanley-Laman Group first reported a position in Johnson & Johnson in Q1 2014 and held it in 42 quarters.
Stanley-Laman Group's Johnson & Johnson position peaked at $2.74M in Q2 2021.
4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Stanley-Laman Group's 13F filing for Q2 2026, filed 5 Aug 2026.